Literature DB >> 11342757

Incidence and management of prolonged charge times in the Medtronic model 7219 implantable cardioverter defibrillator.

D E Mann1, S A Gleason, P A Kelly, A R Easley, M J Reiter.   

Abstract

The Medtronic Jewel PCD model 7219, introduced in 1994, was the first downsized, pectoral implantable cardioverter defibrillator (ICD), and many of these units are approaching or have reached the elective replacement indicator (ERI). Unlike later Medtronic ICDs and most other ICDs, in which ERI is defined by battery voltage, the ERI in the model 7219 series is defined when either the capacitor charge time to full output is repeatedly> or =14.5 s or when battery voltage is< or =4.91 V. In this study we examined which of the two ERI criteria was met first in patients with this device model. We also assessed the effects of manual dumping and recharging and of increasing the automatic capacitor reformation frequency on prolonged charge times. In 16 patients with follow-up <2 years, 15 reached the charge time ERI before battery voltage ERI. Manual dumping and recharging led to spuriously low charge times due to residual charge at the start of recharging, and increasing the automatic capacitor reformation frequency to once a month did not decrease prolonged charge times. Because of persistently prolonged charge times, 15 patients had generator changes. None of these patients had reached battery voltage ERI (battery voltage at time of explantation 5.06+/-0.06 V). Thus in this early pectoral device, prolonged charge times occur commonly before battery voltage ERI is reached. Whether prolonged charge times will have an impact on device longevity in later model ICDs is unknown.

Entities:  

Mesh:

Year:  2001        PMID: 11342757     DOI: 10.1023/a:1011437726676

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  2 in total

1.  Personal and public safety issues related to arrhythmias that may affect consciousness: implications for regulation and physician recommendations. A medical/scientific statement from the American Heart Association and the North American Society of Pacing and Electrophysiology.

Authors:  A E Epstein; W M Miles; D G Benditt; A J Camm; E J Darling; P L Friedman; A Garson; J C Harvey; G A Kidwell; G J Klein; P A Levine; F E Marchlinski; E N Prystowsky; B L Wilkoff
Journal:  Circulation       Date:  1996-09-01       Impact factor: 29.690

2.  Significant differences in charge times among currently available implantable cardioverter defibrillators.

Authors:  D E Mann; P A Kelly; A D Robertson; L Otto; M J Reiter
Journal:  Pacing Clin Electrophysiol       Date:  1999-06       Impact factor: 1.976

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.